Abstract:It appears that the Perflex stent may be used in the iliac arteries with a success rate similar to other stents. However, this preliminary result has to be confirmed in a larger series and after a longer follow-up.
“…Strecker et al berichten über eine kumulative Offenheitsrate des Strecker-Stents von 92 % nach 6 Monaten[3]. Die primäre Offenheitsrate des Perflex-Stents nach 6 ± 12 Monaten liegt bei 93 %[12], die des VIP-Stents bei 91 %[13].…”
Endoluminal therapy of iliac artery lesions with the used stent is safe and effective. The six month patency rate is comparable to the published data of other stents.
“…Strecker et al berichten über eine kumulative Offenheitsrate des Strecker-Stents von 92 % nach 6 Monaten[3]. Die primäre Offenheitsrate des Perflex-Stents nach 6 ± 12 Monaten liegt bei 93 %[12], die des VIP-Stents bei 91 %[13].…”
Endoluminal therapy of iliac artery lesions with the used stent is safe and effective. The six month patency rate is comparable to the published data of other stents.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.